United States · Series B startup

Who invested in Ascend Health

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$20Mraised across 1 round since 2007, from 1 source

Latest round
Series B, $20MMar 2007
Investors
3
See who backed them

The rounds

  1. Mar 2007
    Series B$20M

    From a historical funding record

Founders and team

From Ascend Health's own website: 6 on the team.

  • Zachary NielsenChief Executive
  • Olivia NielsenChief Operating Officer
  • Peter EdwardsChief of Staff
  • Andre GhouseTraining & Compliance Manager
  • Jaiden BurkeCommunity Support Lead
  • Robert Duff-SilsbyMarketing Manager

The exit

ExitBuyerPriceWhen
AcquiredUniversal Health ServicesundisclosedJun 2012

From historical deal records. Wrong? Tell us.

Everyone who backed them

Polaris PartnersVC firm1round
Three Arch PartnersGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ascend Health

Who invested in Ascend Health?

Ascend Health's investors include Polaris Partners, Three Arch Partners and CHL Medical Partners.

How much has Ascend Health raised?

Ascend Health has raised $20M across 1 round since 2007.

When did Ascend Health last raise?

Ascend Health's most recent round was a Series B of $20M in Mar 2007.

What was Ascend Health's biggest round?

Its most recent round, $20M in Mar 2007, is also its largest on record.

Who backed Ascend Health first?

Ascend Health's first round on record, in Mar 2007, was backed by Polaris Partners, Three Arch Partners and CHL Medical Partners.

What stage is Ascend Health at?

Ascend Health's latest named round is a Series B, in Mar 2007.

Where is Ascend Health based?

Ascend Health is based in the United States.

Companies like Ascend Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.